Creating Hope Reauthorization Act of 2024

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7384 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                                H. R. 7384

    To amend the Federal Food, Drug, and Cosmetic Act to extend the 
   authority of the Secretary of Health and Human Services to issue 
  priority review vouchers to encourage treatments for rare pediatric 
                               diseases.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 15, 2024

 Mr. McCaul (for himself, Ms. Eshoo, Mr. Bilirakis, Ms. Barragan, Mrs. 
   Trahan, and Mr. Burgess) introduced the following bill; which was 
            referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
    To amend the Federal Food, Drug, and Cosmetic Act to extend the 
   authority of the Secretary of Health and Human Services to issue 
  priority review vouchers to encourage treatments for rare pediatric 
                               diseases.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Creating Hope Reauthorization Act of 
2024''.

SEC. 2. EXTENSION OF AUTHORITY TO ISSUE PRIORITY REVIEW VOUCHERS TO 
              ENCOURAGE TREATMENTS FOR RARE PEDIATRIC DISEASES.

    Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 360ff(b)(5)) is amended--
            (1) by striking ``September 30, 2024'' each place it 
        appears and inserting ``September 30, 2028''; and
            (2) in subparagraph (B), by striking ``September 30, 2026'' 
        and inserting ``September 30, 2030''.
                                 <all>